Healthy minds from 0–100 years: Optimising the use of European brain imaging cohorts (“Lifebrain”)
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Healthy minds from 0–100 years : Optimising the use of European brain imaging cohorts (“Lifebrain”). / Walhovd, K. B.; Fjell, A. M.; Westerhausen, R.; Nyberg, L.; Ebmeier, K. P.; Lindenberger, U.; Bartrés-Faz, D.; Baaré, W. F.C.; Siebner, H. R.; Henson, R.; Drevon, C. A.; Knudsen, G. P.; Budin-Ljøsne, I.; Penninx, B. W.J.H.; Ghisletta, P.; Rogeberg, O.; Tyler, L.; Bertram, L.; for Lifebrain Consortium.
I: European Psychiatry, Bind 50, 2018, s. 47-56.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Healthy minds from 0–100 years
T2 - Optimising the use of European brain imaging cohorts (“Lifebrain”)
AU - Walhovd, K. B.
AU - Fjell, A. M.
AU - Westerhausen, R.
AU - Nyberg, L.
AU - Ebmeier, K. P.
AU - Lindenberger, U.
AU - Bartrés-Faz, D.
AU - Baaré, W. F.C.
AU - Siebner, H. R.
AU - Henson, R.
AU - Drevon, C. A.
AU - Knudsen, G. P.
AU - Budin-Ljøsne, I.
AU - Penninx, B. W.J.H.
AU - Ghisletta, P.
AU - Rogeberg, O.
AU - Tyler, L.
AU - Bertram, L.
AU - for Lifebrain Consortium
PY - 2018
Y1 - 2018
N2 - The main objective of “Lifebrain” is to identify the determinants of brain, cognitive and mental (BCM) health at different stages of life. By integrating, harmonising and enriching major European neuroimaging studies across the life span, we will merge fine-grained BCM health measures of more than 5,000 individuals. Longitudinal brain imaging, genetic and health data are available for a major part, as well as cognitive and mental health measures for the broader cohorts, exceeding 27,000 examinations in total. By linking these data to other databases and biobanks, including birth registries, national and regional archives, and by enriching them with a new online data collection and novel measures, we will address the risk factors and protective factors of BCM health. We will identify pathways through which risk and protective factors work and their moderators. Exploiting existing European infrastructures and initiatives, we hope to make major conceptual, methodological and analytical contributions towards large integrative cohorts and their efficient exploitation. We will thus provide novel information on BCM health maintenance, as well as the onset and course of BCM disorders. This will lay a foundation for earlier diagnosis of brain disorders, aberrant development and decline of BCM health, and translate into future preventive and therapeutic strategies. Aiming to improve clinical practice and public health we will work with stakeholders and health authorities, and thus provide the evidence base for prevention and intervention.
AB - The main objective of “Lifebrain” is to identify the determinants of brain, cognitive and mental (BCM) health at different stages of life. By integrating, harmonising and enriching major European neuroimaging studies across the life span, we will merge fine-grained BCM health measures of more than 5,000 individuals. Longitudinal brain imaging, genetic and health data are available for a major part, as well as cognitive and mental health measures for the broader cohorts, exceeding 27,000 examinations in total. By linking these data to other databases and biobanks, including birth registries, national and regional archives, and by enriching them with a new online data collection and novel measures, we will address the risk factors and protective factors of BCM health. We will identify pathways through which risk and protective factors work and their moderators. Exploiting existing European infrastructures and initiatives, we hope to make major conceptual, methodological and analytical contributions towards large integrative cohorts and their efficient exploitation. We will thus provide novel information on BCM health maintenance, as well as the onset and course of BCM disorders. This will lay a foundation for earlier diagnosis of brain disorders, aberrant development and decline of BCM health, and translate into future preventive and therapeutic strategies. Aiming to improve clinical practice and public health we will work with stakeholders and health authorities, and thus provide the evidence base for prevention and intervention.
KW - Dementia
KW - Economics and psychiatry
KW - Epidemiology
KW - MRI
KW - Neurodevelopment
KW - Psychiatric disorder
U2 - 10.1016/j.eurpsy.2017.12.006
DO - 10.1016/j.eurpsy.2017.12.006
M3 - Review
AN - SCOPUS:85033366494
VL - 50
SP - 47
EP - 56
JO - European Psychiatry
JF - European Psychiatry
SN - 0924-9338
ER -
ID: 214456909